90 results
Page 3 of 5
8-K
EX-99.1
jfq4e 5cl70k3i8d
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-99.1
1vld5fj83238orudo
7 Nov 19
AbbVie Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Allergan Notes
9:13pm
8-K
EX-99.1
7lahqsths8cj
7 Nov 19
Other Events
9:17am
8-K
3fmwz cbp8s5sch0
7 Nov 19
Other Events
9:17am
8-K
EX-99.2
nt5ccqj
6 Nov 19
Regulation FD Disclosure
3:30pm
8-K
EX-99.1
fnibzm8
25 Oct 19
AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes
8:25am
8-K
nmgbt0o40ijh80
16 Sep 19
Regulation FD Disclosure
7:57am
8-K
z18yy2
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
EX-99.2
q4pf7v0dd meb0ekfb
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
EX-99.1
ww8mj5h
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
nosmp
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
vsmrogp 1fl61q
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-2.1
qa7cxgzcn48 oai
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99.1
q401xlmwju ulpxc
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99
r9hnzjsezf
25 Apr 19
AbbVie Reports First-Quarter 2019 Financial Results
7:45am
PX14A6G
91rfr 7c3jwd90
29 Mar 19
Letter to shareholders
11:12am
424B5
5ftb uk6hz671au1
13 Sep 18
Prospectus supplement for primary offering
12:00am